Relationship between EASI and SCORAD severity assessments for atopic dermatitis

Rishi Chopra; Paras P Vakharia; Ryan Sacotte; Neha Patel; Supriya Immaneni; Takeshia White; Robert Kantor; Derek Y Hsu; Jonathan I Silverberg

doi:10.1016/j.jaci.2017.04.052

Relationship between EASI and SCORAD severity assessments for atopic dermatitis

J Allergy Clin Immunol. 2017 Dec;140(6):1708-1710.e1. doi: 10.1016/j.jaci.2017.04.052. Epub 2017 Jun 15.

Authors

Rishi Chopra¹, Paras P Vakharia¹, Ryan Sacotte¹, Neha Patel¹, Supriya Immaneni¹, Takeshia White¹, Robert Kantor¹, Derek Y Hsu¹, Jonathan I Silverberg²

Affiliations

¹ Department of Dermatology, Feinberg School of Medicine at Northwestern University, Chicago, Ill.
² Departments of Dermatology, Preventive Medicine and Medical Social Sciences, Feinberg School of Medicine at Northwestern University, Chicago, Ill; Northwestern Medicine Multidisciplinary Eczema Center, Chicago, Ill. Electronic address: JonathanISilverberg@gmail.com.

Abstract

The present study shows a complex relationship between EASI and SCORAD. The results provide support for inclusion of objective-SCORAD and/or SCORAD in addition to EASI in clinical trials.

Publication types

Letter
Observational Study
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers / blood
Dermatitis, Atopic / blood*
Female
Humans
Male
Middle Aged
Severity of Illness Index*
Young Adult

Substances

Biomarkers

Grants and funding

K12 HS023011/HS/AHRQ HHS/United States